Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)

Roy Eldor; Noa Avraham; Orit Rosenberg; Miriam Shpigelman; Avivit Golan-Cohen; Tali Cukierman-Yaffe; Eugene Merzon; Assaf Buch

doi:10.2337/dc26-er02a

Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)

Roy Eldor
, Noa Avraham
, Orit Rosenberg
, Miriam Shpigelman
, Avivit Golan-Cohen
, Tali Cukierman-Yaffe
, Eugene Merzon
, Assaf Buch

מדעי התזונה

פרסום מחקרי: פרסום בכתב עת › תגובה / דיון

תקציר

In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

שפה מקורית	אנגלית
עמודים (מ-עד)	361
מספר עמודים	1
כתב עת	Diabetes Care
כרך	49
מספר גיליון	2
מזהי עצם דיגיטלי (DOIs)	https://doi.org/10.2337/dc26-er02a
סטטוס פרסום	פורסם - פבר׳ 2026

גישה למסמך

10.2337/dc26-er02a

קבצים וקישורים אחרים

Link to publication in Scopus

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי

Eldor, R., Avraham, N., Rosenberg, O., Shpigelman, M., Golan-Cohen, A., Cukierman-Yaffe, T., Merzon, E., & Buch, A. (2026). Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690). Diabetes Care, 49(2), 361. https://doi.org/10.2337/dc26-er02a

Eldor, Roy ; Avraham, Noa ; Rosenberg, Orit et al. / Erratum : Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690). ב-: Diabetes Care. 2026 ; כרך 49, מס' 2. עמודים 361.

@article{c396912dd8ff434fabbb547e73eb4e73,

title = "Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607{\textendash}1611), 10.2337/dc25-0690)",

abstract = "In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.",

author = "Roy Eldor and Noa Avraham and Orit Rosenberg and Miriam Shpigelman and Avivit Golan-Cohen and Tali Cukierman-Yaffe and Eugene Merzon and Assaf Buch",

year = "2026",

month = feb,

doi = "10.2337/dc26-er02a",

language = "אנגלית",

volume = "49",

pages = "361",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "2",

}

Eldor, R, Avraham, N, Rosenberg, O, Shpigelman, M, Golan-Cohen, A, Cukierman-Yaffe, T, Merzon, E & Buch, A 2026, 'Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)', Diabetes Care, כרך 49, מס' 2, עמודים 361. https://doi.org/10.2337/dc26-er02a

Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690). / Eldor, Roy; Avraham, Noa; Rosenberg, Orit et al.
ב-: Diabetes Care, כרך 49, מס' 2, 02.2026, עמוד 361.

פרסום מחקרי: פרסום בכתב עת › תגובה / דיון

TY - JOUR

T1 - Erratum

T2 - Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)

AU - Eldor, Roy

AU - Avraham, Noa

AU - Rosenberg, Orit

AU - Shpigelman, Miriam

AU - Golan-Cohen, Avivit

AU - Cukierman-Yaffe, Tali

AU - Merzon, Eugene

AU - Buch, Assaf

PY - 2026/2

Y1 - 2026/2

N2 - In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

AB - In the article cited above, the affiliations for author Assaf Buch were incorrectly given as Diabetes Unit, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, and Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The sole affiliation for this author is Department of Nutritional Sciences, School of Health Sciences, Ariel University, Ariel, Israel. The online version of the article (https://doi.org/10.2337/dc25-0690) has been updated with the correct affiliation information.

UR - https://www.scopus.com/pages/publications/105028171563

U2 - 10.2337/dc26-er02a

DO - 10.2337/dc26-er02a

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 41337783

AN - SCOPUS:105028171563

SN - 0149-5992

VL - 49

SP - 361

JO - Diabetes Care

JF - Diabetes Care

IS - 2

ER -

Eldor R, Avraham N, Rosenberg O, Shpigelman M, Golan-Cohen A, Cukierman-Yaffe T et al. Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690). Diabetes Care. 2026 פבר׳;49(2):361. doi: 10.2337/dc26-er02a